Global Celiac Disease Diagnostics Market Growth 2025-2031
Description
The global Celiac Disease Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Celiac Disease Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Celiac Disease Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Celiac Disease Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Celiac Disease Diagnostics players cover Thermo Fisher Scientific Inc., PRIMA Lab SA, Glutenostics, Inc., NanoRepro AG., Targeted Genomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Celiac Disease Diagnostics Industry Forecast” looks at past sales and reviews total world Celiac Disease Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Celiac Disease Diagnostics sales for 2025 through 2031. With Celiac Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Celiac Disease Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Celiac Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Celiac Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Celiac Disease Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Celiac Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Celiac Disease Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Celiac Disease Diagnostics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Serology Rapid Test Kit
Gene Rapid Detection Kit
Segmentation by Application:
Hospital
Diagnostic Laboratory
Specialty Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc.
PRIMA Lab SA
Glutenostics, Inc.
NanoRepro AG.
Targeted Genomics
YORKTEST Laboratories
Biohit Oyj
Labsystems Diagnostics Oy
RxHome Test
Biomerica
AESKU.GROUP GmbH
LaCAR MDx Technologies
J. Mitra & Co.Pvt.Ltd.
lmaware
Vitrosens Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Celiac Disease Diagnostics market?
What factors are driving Celiac Disease Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celiac Disease Diagnostics market opportunities vary by end market size?
How does Celiac Disease Diagnostics break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
United States market for Celiac Disease Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Celiac Disease Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Celiac Disease Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Celiac Disease Diagnostics players cover Thermo Fisher Scientific Inc., PRIMA Lab SA, Glutenostics, Inc., NanoRepro AG., Targeted Genomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Celiac Disease Diagnostics Industry Forecast” looks at past sales and reviews total world Celiac Disease Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Celiac Disease Diagnostics sales for 2025 through 2031. With Celiac Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Celiac Disease Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Celiac Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Celiac Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Celiac Disease Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Celiac Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Celiac Disease Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Celiac Disease Diagnostics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Serology Rapid Test Kit
Gene Rapid Detection Kit
Segmentation by Application:
Hospital
Diagnostic Laboratory
Specialty Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc.
PRIMA Lab SA
Glutenostics, Inc.
NanoRepro AG.
Targeted Genomics
YORKTEST Laboratories
Biohit Oyj
Labsystems Diagnostics Oy
RxHome Test
Biomerica
AESKU.GROUP GmbH
LaCAR MDx Technologies
J. Mitra & Co.Pvt.Ltd.
lmaware
Vitrosens Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Celiac Disease Diagnostics market?
What factors are driving Celiac Disease Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celiac Disease Diagnostics market opportunities vary by end market size?
How does Celiac Disease Diagnostics break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
111 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Celiac Disease Diagnostics by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Celiac Disease Diagnostics by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
